These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 17675185)

  • 21. Induction of hepatitis C virus E1 envelope protein-specific immune response can be enhanced by mutation of N-glycosylation sites.
    Fournillier A; Wychowski C; Boucreux D; Baumert TF; Meunier JC; Jacobs D; Muguet S; Depla E; Inchauspé G
    J Virol; 2001 Dec; 75(24):12088-97. PubMed ID: 11711599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-mediated immune responses in rainbow trout after DNA immunization against the viral hemorrhagic septicemia virus.
    Utke K; Kock H; Schuetze H; Bergmann SM; Lorenzen N; Einer-Jensen K; Köllner B; Dalmo RA; Vesely T; Ototake M; Fischer U
    Dev Comp Immunol; 2008; 32(3):239-52. PubMed ID: 17629943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune responses to hepatitis C virus structural and nonstructural proteins induced by plasmid DNA immunizations.
    Gordon EJ; Bhat R; Liu Q; Wang YF; Tackney C; Prince AM
    J Infect Dis; 2000 Jan; 181(1):42-50. PubMed ID: 10608749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene.
    Frelin L; Ahlén G; Alheim M; Weiland O; Barnfield C; Liljeström P; Sällberg M
    Gene Ther; 2004 Mar; 11(6):522-33. PubMed ID: 14999224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction of, and T-helper (Th)1/Th2 immune responses to, a herpes simplex virus type 2 glycoprotein D-cytotoxic T-lymphocyte epitope DNA vaccine.
    Huilan Y; Cui Z; Jianyong F; Lei G; Wei Q
    Clin Exp Dermatol; 2010 Jul; 35(5):537-42. PubMed ID: 20497188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of complex B cell epitopes on woodchuck hepatitis virus surface antigens by using plasmids encoding chimeric proteins and DNA immunization.
    Zheng X; Schirmbeck R; Hilken G; Waters JA; Yang D; Reimann J; Roggendorf M; Lu M
    Virology; 2002 Mar; 294(2):342-53. PubMed ID: 12009876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of E2 and E1 glycosylation on specific membrane fusion in rubella virus strain JR23.
    Wu B; Liu X; Wang Z
    Intervirology; 2009; 52(2):68-77. PubMed ID: 19401615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immune responses induced by the suicidal DNA vaccines co-expressing the GP5 protein of PRRSV and the E2 protein of CSFV in mice].
    Sun J; Zhao H; Li N; Sun Y; Xi Z; Zhou Y; Wang Y; Qi Q; Lu C; Qiu H
    Sheng Wu Gong Cheng Xue Bao; 2008 Oct; 24(10):1714-22. PubMed ID: 19149182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins].
    Goffard A; Lazrek M; Bocket L; Dewilde A; Hober D
    Ann Biol Clin (Paris); 2007; 65(3):237-46. PubMed ID: 17502294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of bovine respiratory syncytial virus F glycoprotein N-linked glycans on in vitro expression and on antibody responses in BALB/c mice.
    Klink HA; Brady RP; Topliff CL; Eskridge KM; Srikumaran S; Kelling CL
    Vaccine; 2006 Apr; 24(16):3388-95. PubMed ID: 16504352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A candidate vaccine based on the hepatitis C E1 protein: tolerability and immunogenicity in healthy volunteers.
    Leroux-Roels G; Depla E; Hulstaert F; Tobback L; Dincq S; Desmet J; Desombere I; Maertens G
    Vaccine; 2004 Aug; 22(23-24):3080-6. PubMed ID: 15297058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus-like particles induce virus-specific humoral and cellular immune responses in mice.
    Lechmann M; Murata K; Satoi J; Vergalla J; Baumert TF; Liang TJ
    Hepatology; 2001 Aug; 34(2):417-23. PubMed ID: 11481628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of immunization in mice with recombinant DNA encoding the hepatitis C virus structural protein.
    Dou J; Liu K; Chen Z; Wo J; He N; Liu Y; Zhang M; Wang X; Xu C
    Chin Med J (Engl); 1999 Nov; 112(11):1036-9. PubMed ID: 11721468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cellular immune responses of recombinant hepatitis B (rHB) vaccine and HBsAG derived from Hansenula polymorpha cells].
    Hu ZY; He P; Zhang R; Fang X; Zhu FC; Qiu SH; Li HM; Wang H; Liang ZL; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jul; 29(7):706-11. PubMed ID: 19031766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunization of chimpanzees with an envelope protein-based vaccine enhances specific humoral and cellular immune responses that delay hepatitis C virus infection.
    Puig M; Major ME; Mihalik K; Feinstone SM
    Vaccine; 2004 Feb; 22(8):991-1000. PubMed ID: 15161076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune responses against hepatitis C virus structural proteins following genetic immunisation.
    Inchauspé G; Major ME; Nakano I; Vivitski L; Maisonnas M; Trépo C
    Dev Biol Stand; 1998; 92():163-8. PubMed ID: 9554271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C virus envelope glycoprotein E1 originates in the endoplasmic reticulum and requires cytoplasmic processing for presentation by class I MHC molecules.
    Selby M; Erickson A; Dong C; Cooper S; Parham P; Houghton M; Walker CM
    J Immunol; 1999 Jan; 162(2):669-76. PubMed ID: 9916684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
    Vietheer PT; Boo I; Drummer HE; Netter HJ
    Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant retrovirus-like particle forming DNA vaccines in prime-boost immunization and their use for hepatitis C virus vaccine development.
    Desjardins D; Huret C; Dalba C; Kreppel F; Kochanek S; Cosset FL; Tangy F; Klatzmann D; Bellier B
    J Gene Med; 2009 Apr; 11(4):313-25. PubMed ID: 19248137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of immunological adjuvants: GM-CSF (granulocyte-monocyte colony stimulating factor) and IL-23 (interleukin-23) on immune responses generated against hepatitis C virus core DNA vaccine.
    Hartoonian C; Ebtekar M; Soleimanjahi H; Karami A; Mahdavi M; Rastgoo N; Azadmanesh K
    Cytokine; 2009 Apr; 46(1):43-50. PubMed ID: 19278866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.